Search

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

GDPR Compliance

We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

U.K. regulator reports 30 blood clot cases linked to AstraZeneca COVID-19 vaccine

Published on April 03, 2021 at 04:29 PM

Britain's medicines regulator said it has identified 30 cases of rare blood clot events associated with the AstraZeneca COVID-19 vaccine but stressed the benefits “continue to outweigh any risks.”

The Medicines and Healthcare Regulatory Agency said the risk associated with this type of blood clot is “very small” and that the public should continue to take up the vaccine when offered it.

Read more: AstraZeneca COVID-19 vaccine not recommended for those under 55, NACI says

The agency said late Friday the cases relate to the period up to March 24, during which 18.1 million doses of the vaccine had been administered and that it hadn't received any similar reports with regard to the Pfizer-BioNTech vaccine.

Concerns over the AstraZeneca vaccine prompted some countries including Canada, France, Germany and the Netherlands to restrict its use to older people.

The World Health Organization has urged countries to continue using the jab.

Prev Article

Health officials seek to convince skeptical public of COVID-19 vaccine safety

Next Article

Shipping backlog in Suez Canal to end today, official says

Related to this topic:

Comments (0):

Be the first to write a comment.

Post Comment

Your email address will not be published. Required fields are marked *